|
ABHD3 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.243600E-02 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.346300E-02 |
| Normal-vs-AfricanAmerican |
1.650210E-01 |
| Normal-vs-Asian |
4.416300E-02 |
| Caucasian-vs-AfricanAmerican |
9.705600E-01 |
| Caucasian-vs-Asian |
3.576300E-03 |
| AfricanAmerican-vs-Asian |
5.402200E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.757800E-02 |
| Normal-vs-Female |
8.310200E-02 |
| Male-vs-Female |
4.221800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.543800E-02 |
| Normal-vs-Age(41-60Yrs) |
9.686000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.196200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.295690E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.768400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.444000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.997200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.984800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.753600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.251600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
3.644100E-02 |
| Normal-vs-Pheochromocytoma |
6.907600E-02 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.477400E-01 |
| Paraganglioma-vs-Pheochromocytoma |
2.49119999999881E-05 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
3.817800E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.962000E-01 |
|
|
